Spontaneous tumor incidence in rasH2 mice: Review of internal data and published literature

Toxicologic Pathology

Volumn 40, Issue 4, 2012, Pages 614-623

  Nambiar, Prashant R ^a   Turnquist, Susan E ^b   Morton, Daniel ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

background; carcinogenicity; historical control; mice; ras; rasH2

Indexed keywords

CARCINOGEN; METHYLNITROSOUREA; TROGLITAZONE;

ANGIOSARCOMA; BIOASSAY; BODY WEIGHT; CANCER INCIDENCE; CARCINOGENICITY; HARDER GLAND; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; LYMPHOMA; MEDICAL LITERATURE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; SURVIVAL RATE; TRANSGENIC MOUSE;

ANIMALS; BODY WEIGHT; CARCINOGENICITY TESTS; DISEASE MODELS, ANIMAL; FEMALE; GENES, RAS; MALE; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; SURVIVAL ANALYSIS;

MUS; MUS MUSCULUS; RATTUS;

EID: 84861820471     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311436181     Document Type: Review

References (26)

1. Alden C. L., Lynn A., Bourdeau A., Morton D., Sistare F. D., Kadambi V. J., Silverman L.. A critical review of the effectiveness of rodent pharmaceutical carcinogenesis testing in predicting for human risk. Vet Pathol. 2009 ; 48: 772-84
2. Alden C., Smith P., Morton D.. Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development. Toxicol Pathol. 2002 ; 30: 135-8
3. Ando K., Saitoh A., Hino O., Takahashi R., Kimura M., Katsuki M.. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res. 1992 ; 52: 978-82
4. International Conference on Harmonization: Guidance on testing for carcinogenicity of pharmaceuticals. Federal Register. 1998 ; 63: 8983-6
5. Cho W. S., Jeong J., Choi M., Park S. N., Han B. S., Son W. C. 26-week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice. Arch Toxicol. 2010 ; 85: 59-66
6. Friedrich A., Olejniczak K. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009). Regul Toxicol Pharmacol. 2011 ; 60: 225-48
7. Jin M., Takahashi M., Moto M., Muguruma M., Ito K., Watanabe K., Kenmochi Y., Kono T., Hasumi K., Mitsumori K.. Carcinogenic susceptibility of rasH2 mice to troglitazone. Arch Toxicol. 2007 ; 81: 883-94
8. Keenan C., Elmore S., Francke-Carroll S., Kemp R., Kerlin R., Peddada S., Pletcher J., Rinke M., Schmidt S. P., Taylor I., Wolf D. C.. Best practices for use of historical control data of proliferative rodent lesions. Toxicol Pathol. 2009 ; 37: 679-93
9. Long G. G., Morton D., Peters T., Short B., Skydsgaard M.. Alternative mouse models for carcinogenicity assessment: industry use and issues with pathology interpretation. Toxicol Pathol. 2010 ; 38: 43-50
10. MacDonald J., French J. E., Gerson R. J., Goodman J., Inoue T., Jacobs A., Kasper P., Keller D., Lavin A., Long G., McCullough B., Sistare F. D., Storer R., van der Laan J. W.. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. Toxicol Sci. 2004 ; 77: 188-94
11. Machida K., Urano K., Yoshimura M., Tsutsumi H., Nomura T., Usui T.. Carcinogenic comparative study on rasH2 mice produced by two breeding facilities. J Toxicol Sci. 2008 ; 33: 493-501
12. Mitsumori K.. Evaluation on carcinogenicity of chemicals using transgenic mice. Toxicology. 2002 ; 181-182: 241-4
13. Mitsumori K., Koizumi H., Nomura T., Yamamoto S.. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol. 1998 ; 26: 520-31
14. Mohr U. International Classification of Rodent Tumors: The Mouse. Heidelberg, Germany: Springer-Verlag ; 2001 :
15. Morton D., Alden C. L., Roth A. J., Usui T.. The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol. 2002 ; 30: 139-46
16. Morton D., Bailey K. L., Stout C. L., Weaver R. J., White K. A., Lorenzen M. J., Ball D. J.. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies. Toxicol Pathol. 2008 ; 36: 926-31
17. Okamura M., Moto M., Muguruma M., Ito T., Jin M., Kashida Y., Mitsumori K.. A 26-week carcinogenicity study of 2-amino-3-methylimidazo[4,5-f]quinoline in rasH2 mice. Toxicol Pathol. 2006 ; 34: 199-205
18. Okamura M., Unami A., Moto M., Muguruma M., Ito T., Jin M., Oishi Y., Kashida Y., Mitsumori K.. The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice. Cancer Lett. 2007 ; 245: 321-30
19. Ozaki M., Ozaki K., Watanabe T., Uwagawa S., Okuno Y., Shirai T.. Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains. Toxicol Pathol. 2005 ; 33: 267-71
20. Palazzi X., Kergozien-Framery S.. Use of rasH2 transgenic mice for carcinogenesis testing of medical implants. Exp Toxicol Pathol. 2009 ; 61: 433-41
21. Renne R., Brix A., Harkema J., Herbert R., Kittel B., Lewis D., March T., Nagano K., Pino M., Rittinghausen S., Rosenbruch M., Tellier P., Wohrmann T. Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol. 2009 ; 37: 5S - 73
22. Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M.. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene. 1990 ; 5: 1195-200
23. Suemizu H., Muguruma K., Maruyama C., Tomisawa M., Kimura M., Hioki K., Shimozawa N., Ohnishi Y., Tamaoki N., Nomura T.. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol Carcinog. 2002 ; 34: 1-9
24. Tamaoki N.. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol. 2001 ; 29 ((Suppl.)). 81-9
25. Usui T., Mutai M., Hisada S., Takoaka M., Soper K. A., McCullough B., Alden C.. CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol. 2001 ; 29 ((Suppl.)). 90-108
26. Wall R. J., Shani M.. Are animal models as good as we think?. Theriogenology. 2008 ; 69: 2-9